The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Which treatment strategies are the most promising for locally advanced resectable human papillomavirus-associated oropharyngeal cancers?
 
Tomoya Yokota
Honoraria - Abbott Japan; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Merck Serono; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bayer; Merck Serono; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Chugai/Roche (Inst); Incyte (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Yoshiyuki Iida
No Relationships to Disclose
 
Tomoyuki Kamijo
No Relationships to Disclose
 
Kotaro Morita
No Relationships to Disclose
 
Takashi Mukaigawa
No Relationships to Disclose
 
Yukio Nishiya
No Relationships to Disclose
 
Noriko Hamaguchi
No Relationships to Disclose
 
Satoshi Hamauchi
No Relationships to Disclose
 
Sadayuki Kawai
No Relationships to Disclose
 
Yusuke Onozawa
Honoraria - Bayer
 
Hiromichi Shirasu
No Relationships to Disclose
 
Hirofumi Ogawa
No Relationships to Disclose
 
Tsuyoshi Onoe
No Relationships to Disclose
 
Masahiro Nakagawa
No Relationships to Disclose
 
Tetsuro Onitsuka
No Relationships to Disclose